HIGHLIGHTS
- who: Almog Shalit et al. from the Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece have published the research work: Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment, in the Journal: Cancers 2023, 15, 375 Endocrine of 31/01/2021
- what: In this review the authors focus on immune-related that affect around 10% of all treated patients. In the current review, the authors present an overview of proposed biomarkers for endocrine immune-related adverse effects in patients receiving immune checkpoint inhibitor therapy.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.